All In MedTech

Device Trial Radar · NCT04701931

OCT Angiography Software Evaluation Study

Topcon Maestro2 OCT Angiography Software Evaluation Study

Last checked: Nov 19, 2026Latest source record: Jul 5, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

135

Actual

Start

Jan 7, 2021

Primary completion

Nov 9, 2022

Study completion Jun 6, 2023

Sponsor

Lead sponsor
Topcon CorporationNot on our public-company list
Sponsor type
Industry
First posted
Jan 8, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Comparisons for vascular structure visualization in the retina and choroid.

Conditions

  • Retina Condition Followed by Fluorescein Angiography Imaging

Interventions

  • Maestro2 OCTADevice

    The Maestro2 OCTA with SS-OCT Angio software is an OCT with a fundus camera used for diagnostic purposes

  • Cirrus HD-OCT 5000Device

    The Zeiss Cirrus HD-OCT 5000 is an OCT used for diagnostic purposes

  • TRC-50DXDevice

    The TRC-50DX retinal camera images the fundus used for diagnostic purposes

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. OCTA image qualityTime frame: Day 1
  2. Visibility of key anatomical vascular featuresTime frame: Day 1
  3. Identification of key pathological vascular featuresTime frame: Day 1

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Orange County Retina Medical Group

    Santa Ana, California

  • Southeast Retina Center

    Augusta, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.